Streptogramins: an answer to antibiotic resistance in gram-positive bacteria
- 1 August 1998
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 352 (9128) , 591-592
- https://doi.org/10.1016/s0140-6736(05)79570-2
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Characterization of Vancomycin-Resistant Enterococcus faecium Isolates from the United States and Their Susceptibility In Vitro to Dalfopristin-QuinupristinAntimicrobial Agents and Chemotherapy, 1998
- Antimicrobial Resistance in Enterococci Isolated from Turkey Flocks Fed VirginiamycinAntimicrobial Agents and Chemotherapy, 1998
- In-vitro activities of ciprofloxacin, levofloxacin, lomefloxacin, ofloxacin, pefloxacin, sparfloxacin and trovafloxacin against gram-positive and gram-negative pathogens from respiratory tract infections.Journal of Antimicrobial Chemotherapy, 1997
- Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibilityJournal of Antimicrobial Chemotherapy, 1997
- Inhibition of protein synthesis by streptogramins and related antibioticsJournal of Antimicrobial Chemotherapy, 1997
- In-vitro and in-vivo antibacterial activity of quinupristin/dalfopristinJournal of Antimicrobial Chemotherapy, 1997
- Comparative in-vitro activity of quinupristin/dalfopristin against Enterococcus spp.Journal of Antimicrobial Chemotherapy, 1997
- Resistance to Glycopeptides in EnterococciClinical Infectious Diseases, 1997
- Antimicrobial-Drug ResistanceNew England Journal of Medicine, 1996
- Quinupristin/Dalfopristin: Spectrum of Activity, Pharmacokinetics, and Initial Clinical ExperienceMicrobial Drug Resistance, 1995